OPTH
Optimi Health Corp. Common Shares (OPTH)
Healthcare • NASDAQ • $4.64-4.72%
- Symbol
- OPTH
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $4.64
- Daily Change
- -4.72%
- Market Cap
- $27.45M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $6.40
- 52W Low
- $4.00
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 1.59
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is b…
Company websiteResearch OPTH on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.